S&CO Inc
- SEC CIK
- 0001082461
- Latest filing
- Aug 6, 2026
RPRX holding history
Royalty Pharma plc in every 13F filed by S&CO Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
RPRX overviewAll 13F holders of RPRXFull Q2 2026 holdings
- Shares (Q2 2026)
- 358,302
- Value
- $20.1M
- % of portfolio
- 1.2%
- Quarters held
- 22
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 358,302 | $20.1M | 1.2% | −750.0% | Reduced | Holders |
| Q1 2026 | 358,377 | $17.2M | 1.1% | 00.0% | Unchanged | Holders |
| Q4 2025 | 358,377 | $13.8M | 0.9% | +1400.0% | Added | Holders |
| Q3 2025 | 358,237 | $12.6M | 0.8% | +700.0% | Added | Holders |
| Q2 2025 | 358,167 | $12.9M | 0.8% | 00.0% | Unchanged | Holders |
| Q1 2025 | 358,167 | $11.1M | 0.7% | +50.0% | Added | Holders |
| Q4 2024 | 358,162 | $9.14M | 0.6% | −4,323−1.2% | Reduced | Holders |
| Q3 2024 | 362,485 | $10.3M | 0.7% | +4,220+1.2% | Added | Holders |
| Q2 2024 | 358,265 | $9.45M | 0.7% | +17,210+5.0% | Added | Holders |
| Q1 2024 | 341,055 | $10.4M | 0.7% | +8,945+2.7% | Added | Holders |
| Q4 2023 | 332,110 | $9.33M | 0.7% | +78,500+31.0% | Added | Holders |
| Q3 2023 | 253,610 | $6.88M | 0.6% | +29,390+13.1% | Added | Holders |
| Q2 2023 | 224,220 | $6.89M | 0.6% | +71,290+46.6% | Added | Holders |
| Q1 2023 | 152,930 | $5.51M | 0.5% | −6,985−4.4% | Reduced | Holders |
| Q4 2022 | 159,915 | $6.32M | 0.6% | 00.0% | Unchanged | Holders |
| Q3 2022 | 159,915 | $6.42M | 0.6% | 00.0% | Unchanged | Holders |
| Q2 2022 | 159,915 | $6.72M | 0.6% | +200.0% | Added | Holders |
| Q1 2022 | 159,895 | $6.23M | 0.4% | +14,660+10.1% | Added | Holders |
| Q4 2021 | 145,235 | $5.79M | 0.4% | +52,385+56.4% | Added | Holders |
| Q3 2021 | 92,850 | $3.35M | 0.3% | +31,590+51.6% | Added | Holders |
| Q2 2021 | 61,260 | $2.51M | 0.2% | +2,520+4.3% | Added | Holders |
| Q1 2021 | 58,740 | $2.56M | 0.2% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.